Editorial: Organ crosstalk in the pathophysiology and treatment of type-2 diabetes.

Autor: Lorza-Gil E; Department of Internal Medicine IV, Division of Endocrinology, Diabetology and Nephrology, University Hospital Tübingen, Tübingen, Germany.; Institute for Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany.; German Center for Diabetes Research (DZD e. V.), Neuherberg, Germany., Ekim B; German Center for Diabetes Research (DZD e. V.), Neuherberg, Germany.; Joint Heidelberg-Institute for Diabetes and Cancer (IDC) Helmholtz Center Munich Translational Diabetes Program, Department of Internal Medicine, Heidelberg University Hospital, Heidelberg, Germany., Sancar G; Department of Internal Medicine IV, Division of Endocrinology, Diabetology and Nephrology, University Hospital Tübingen, Tübingen, Germany.; Institute for Diabetes Research and Metabolic Diseases (IDM) of the Helmholtz Center Munich at the University of Tübingen, Tübingen, Germany.; German Center for Diabetes Research (DZD e. V.), Neuherberg, Germany.
Jazyk: angličtina
Zdroj: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2024 Feb 22; Vol. 15, pp. 1379994. Date of Electronic Publication: 2024 Feb 22 (Print Publication: 2024).
DOI: 10.3389/fendo.2024.1379994
Abstrakt: Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Databáze: MEDLINE